Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Photodynamic Therapy for SARS-CoV-2 Viral Reduction in the Upper Airway in PCR-positive Asymptomatic Individuals.

NCT05184205 is registered in ClinicalTrials.gov with Ondine Biomedical Inc. as lead sponsor.

NCT NCT05184205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05184205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Photodynamic Therapy for SARS-CoV-2 Viral Reduction in the Upper Airway in PCR-positive Asymptomatic Individuals.
Lead sponsor
Ondine Biomedical Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 20, 2021
Completion date
May 30, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 respiratory infection, sars-cov-2 acute respiratory disease